M

Main Line Health

Biomedical research division advancing cancer science

Nurse Practitioner - Hospitalist Medicine and ICU

Full-Time
No salary listed
Junior
Newtown Square, PA, USA
In Person
Medical, Clinical & VeterinaryAdvanced Practice Providers

About the job

Requirements
  • Two years Nurse Practitioner experience in an Intensive Care Unit setting is required.
  • Completion of a Nurse Practitioner program is required.
  • Licensed by the Pennsylvania State Board of Certification by Board of Nurse Examiners as a Certified Registered Nurse Practitioner (CRNP)
  • BLS certification required
  • Current license to practice medicine in the Commonwealth of Pennsylvania without restriction
  • Prescriptive Authority and Collaborative Agreement with the Pennsylvania State Board of Nursing (CRNPs)
  • Registration with the Drug Enforcement Administration to prescribe, without restriction or limitation
  • Current ACLS certification required
  • Credentialing processes completed by Main Line Health and Main Line HealthCare resulting in temporary or permanent privileges and successful payer enrollment
Responsibilities
  • Provide per diem coverage in Hospitalist Medicine and Intensive Care Unit departments across Main Line Health facilities.
  • Travel between all Main Line Health hospitals to fulfill per diem assignments.
  • Perform acts of medical diagnosis or prescription of medical therapeutic or corrective measures in collaboration with attending physicians and residents.
  • Exercise independent judgment and decision-making and consult with other members of the health care team as needed.
Desired Qualifications
  • Minimum of two years nursing experience in a critical care setting (ICU) is preferred.

About the company

Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Lancaster, Pennsylvania

Founded

1927

Get referred to Main Line Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fitch kept Main Line Health at AA with a stable outlook on October 28, 2025.
  • June 2026 revenue reached $2.1 billion, aided by Crozer closures shifting regional demand.
  • Paoli’s June 16, 2026 expansion adds 108 beds and supports higher-acuity volume growth.

What critics are saying

  • The January 2025 200-person layoff exposed reimbursement pressure and overhead dependence.
  • The October 2025 NLRB case with Local 835 signals ongoing labor friction at Lankenau.
  • The August 2026 whistleblower lawsuit over cardiac complications threatens trust, referrals, and surgeon recruitment.

What makes Main Line Health unique

  • LIMR gives Main Line Health a rare translational research engine inside a hospital system.
  • Paoli, Lankenau, Bryn Mawr, and Riddle create a tightly integrated Philadelphia suburban network.
  • The 2026 Saint Joseph’s exclusive-provider deal expands brand visibility beyond traditional hospital care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Pension
  • 403(b) Retirement Plan
  • Unlimited Paid Time Off
  • Tuition Reimbursement
  • Wellness Program
  • Family Planning Benefits

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

4%
PR Newswire
Nov 22nd, 2024
Independence Blue Cross Launches Epic Payer Platform To Transform Care Coordination And Boost Member Health Outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time. "We're excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well," said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross

Managed Healthcare Executive
Feb 16th, 2022
Lankenau Institute For Medical Research hired George Prendergast as president and CEO on Jan 1st 04'.

When George Prendergast was appointed president and CEO of the Lankenau Institute of Medical Research (LIMR) in 2004, he coined the term “acapreneurial” as a mashup for the model he wanted to implement — inventions and startup incubation alongside traditional academic goals of research, new knowledge and its validation.